How much does Fluorescein Sodium and Benoxinate Hydrochloride cost?

Pricing for Fluorescein Sodium and Benoxinate Hydrochloride varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does Fluorescein Sodium and Benoxinate Hydrochloride need prior authorization?

Fluorescein Sodium and Benoxinate Hydrochloride appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for Fluorescein Sodium and Benoxinate Hydrochloride?

We haven't verified an active copay card or PAP for Fluorescein Sodium and Benoxinate Hydrochloride in our current data. Check NeedyMeds or RxAssist for independent directories, or submit what you find via our "Report a broken link" form.

What is Fluorescein Sodium and Benoxinate Hydrochloride used to treat?

Fluorescein Sodium and Benoxinate Hydrochloride (generic: Fluorescein Sodium and Benoxinate Hydrochloride) is indicated for Corneal Abrasion. Click any condition name on this page for more detail.

Fluorescein Sodium and Benoxinate Hydrochloride

Generic: Fluorescein Sodium and Benoxinate Hydrochloride

Verified·Apr 23, 2026

Manufacturer: Bausch Lomb
NDC: 24208-734
RxCUI: 2287005
Route: OPHTHALMIC
ICD-10 indication: S05.00XA

Affordability Check

How much will you actually pay for Fluorescein Sodium and Benoxinate Hydrochloride?

In 30 seconds, see every legitimate way to afford Fluorescein Sodium and Benoxinate Hydrochloride — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Fluorescein Sodium and Benoxinate Hydrochloride

What is this medication? Fluorescein sodium and benoxinate hydrochloride is a combination ophthalmic solution used primarily by eye care professionals during diagnostic procedures. This medication contains a coloring agent called fluorescein, which acts as a diagnostic dye, and a local anesthetic known as benoxinate. When applied to the eye, the anesthetic provides temporary numbness to the surface, allowing the healthcare provider to perform examinations or minor procedures without causing discomfort to the patient.

This specific combination is most frequently utilized for tonometry, which is the process of measuring the internal pressure of the eye to check for conditions such as glaucoma. The fluorescein dye allows the clinician to see the surface of the eye more clearly under a specific blue light, while the benoxinate ensures the patient does not feel the instrument touching the cornea. It may also be used for the removal of small foreign objects from the eye or for certain diagnostic tests that require a brief period of localized anesthesia.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Fluorescein Sodium and Benoxinate Hydrochloride.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Fluorescein Sodium and Benoxinate Hydrochloride →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for Fluorescein Sodium and Benoxinate Hydrochloride →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Fluorescein Sodium and Benoxinate Hydrochloride. Official source: DailyMed (NLM) · Label effective May 12, 2025

Indications and usage

1 INDICATIONS AND USAGE Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is a combination of fluorescein sodium, a disclosing agent and benoxinate hydrochloride, a local ester anesthetic indicated for procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic. ( 1 )

Dosage and administration

2 DOSAGE AND ADMINISTRATION Instill 1 to 2 drops topically in the eye as needed. Instill 1 to 2 drops topically in the eye as needed to achieve adequate anesthesia. ( 2 )

Contraindications

4 CONTRAINDICATIONS Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is contraindicated in patients with known hypersensitivity to any component of this product. Known hypersensitivity to any component of this product. ( 4 )

Warnings and precautions

5 WARNINGS AND PRECAUTIONS Corneal Toxicity : Prolonged use or abuse may lead to corneal epithelial toxicity and manifest as epithelial defects which may progress to permanent corneal damage. ( Error! Hyperlink reference not valid. ) Corneal Injury : Patients should not touch the eye for approximately 20 minutes after using anesthetic as accidental injuries can occur due to insensitivity of the eye. ( 5.2 ) 5.1 Corneal Toxicity Prolonged use or abuse may lead to corneal epithelial toxicity and may manifest as epithelial defects which may progress to permanent corneal damage with accompanying visual loss. 5.2 Corneal Injury Due to Insensitivity Patients should not touch the eye for approximately 20 minutes after using this anesthetic as accidental injuries can occur due to insensitivity of the eye.

Adverse reactions

6 ADVERSE REACTIONS The following serious ocular adverse reactions are described elsewhere in the labeling: Corneal Toxicity [see Warnings and Precautions (5.1) ] Corneal Injury Due to Insensitivity [see Warnings and Precautions (5.2) ] The following adverse reactions have been identified following use of Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4%: ocular hyperemia, burning, stinging, eye irritation, blurred vision and punctate keratitis. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The most common ocular adverse events are: stinging, burning and conjunctival redness. ( 6) To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Use in pregnancy

8.1 Pregnancy Risk Summary There are no available data on the use of Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% in pregnant women to inform any drug associated risk. Adequate animal reproduction studies have not been conducted with fluorescein sodium and/or benoxinate hydrochloride. Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% should be given to a pregnant woman only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Corneal Abrasion

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

Step therapy

Copay tier

—

Medicare Part D

—

Related drugs

How this page is sourced

Drug identity verified against openFDA NDC Directory.
Label text (when shown) originates from NLM DailyMed.
Copay and assistance URLs verified periodically; if you hit a broken link, tell us.